SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-062302
Filing Date
2024-03-07
Accepted
2024-03-07 17:04:14
Documents
5
Effectiveness Date
2024-03-07

Document Format Files

Seq Description Document Type Size
1 S-8 d809385ds8.htm S-8 48041
2 EX-5.1 d809385dex51.htm EX-5.1 6695
3 EX-23.1 d809385dex231.htm EX-23.1 1608
4 EX-FILING FEES d809385dexfilingfees.htm EX-FILING FEES 19780
5 GRAPHIC g809385dsp7.jpg GRAPHIC 10869
  Complete submission text file 0001193125-24-062302.txt   92508
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277756 | Film No.: 24731124
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)